Boothbay Fund Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$588K | – | 1862 |
|
|
2023
Q4 | $588K | Buy |
+10,000
| New | +$588K | 0.02% | 791 |
|
|
2023
Q2 | – | Sell |
-6,196
| Closed | -$230K | – | 2205 |
|
|
2023
Q1 | $230K | Sell |
6,196
-14,040
| -69% | -$522K | ﹤0.01% | 1428 |
|
|
2022
Q4 | $917K | Buy |
+20,236
| New | +$917K | 0.02% | 769 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2091 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2035 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1988 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1639 |
|
|
2020
Q4 | – | Sell |
-4,066
| Closed | -$675K | – | 1330 |
|
|
2020
Q3 | $675K | Buy |
+4,066
| New | +$675K | 0.04% | 472 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1029 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1030 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 955 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 860 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 847 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 830 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 866 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 866 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 823 |
|